ZTS Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (2 Mai 2024 @ 22:00):

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally...

Stats
Tagesvolumen	5.32M
Durchschnittsvolumen	3.65M
Marktkapitalisierung	76.48B
EPS	$0 ( 2024-05-02 )
Nächstes Ertragsdatum	( $1.340 ) 2024-05-22
Last Dividend	$0.375 ( 2023-10-31 )
Next Dividend	$0 ( N/A )
P/E	32.98
ATR14	$0.175 (0.10%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-18	Lagano Roxanne	Sell	923	Common Stock
2024-04-05	Lagano Roxanne	Buy	281	Phantom Stock Unit
2024-04-05	Mamilli Wafaa	Buy	411	Phantom Stock Unit
2024-04-05	Joseph Wetteny	Buy	581	Phantom Stock Unit
2024-04-05	Driscoll Rimma	Buy	16	Phantom Stock Unit

INSIDER POWER
-16.30
Last 100 transactions
Buy: 87 523 \| Sell: 122 271

Volumen Korrelation

Lang: -0.63 (weak negative)

Kurz: 0.48 (neutral)

Signal:(33.944) Neutral

Zoetis Inc Korrelation

10 Am meisten positiv korreliert

10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Zoetis Inc Korrelation - Währung/Rohstoff

0.28
( neutral )

0.14
( neutral )

0.00
( neutral )

-0.14
( neutral )

-0.55
( weak negative )

-0.28
( neutral )

Zoetis Inc Finanzdaten

Annual	2023
Umsatz:	$8.54B
Bruttogewinn:	$5.83B (68.28 %)
EPS:	$5.08

FY	2023
Umsatz:	$8.54B
Bruttogewinn:	$5.83B (68.28 %)
EPS:	$5.08

FY	2022
Umsatz:	$8.08B
Bruttogewinn:	$5.63B (69.63 %)
EPS:	$4.51

FY	2021
Umsatz:	$7.78B
Bruttogewinn:	$5.47B (70.38 %)
EPS:	$4.28

Financial Reports:

No articles found.

Zoetis Inc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.325 (N/A)	$0.325 (N/A)	$0.375 (N/A)	$0.375 (N/A)	$0.375 (N/A)	$0.375 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Zoetis Inc Dividend Information - Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.74 - Stable (14.82%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.0650	2013-04-29
Last Dividend	$0.375	2023-10-31
Next Dividend	$0	N/A
Payout Date	2023-12-01
Next Payout Date	N/A
# dividends	43	--
Total Paid Out	$7.38	--
Avg. Dividend % Per Year	0.50%	--
Score	4.53	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	5.74
Div. Directional Score	8.00	--

Next Divdend (Est)
(2024-07-18)

$0.386 Estimate 39.27 %

Dividend Stability

0.79 Good

Dividend Score

4.53

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2013	$0.195	0.63%
2014	$0.288	0.89%
2015	$0.332	0.77%
2016	$0.380	0.80%
2017	$0.420	0.78%
2018	$0.504	0.70%
2019	$0.656	0.78%
2020	$0.800	0.60%
2021	$1.000	0.61%
2022	$1.300	0.56%
2023	$1.500	1.02%
2024	$0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
LOMA	Dividend Knight	2023-06-30	Quarterly	2	5.23%	8.53
PHK	Dividend Royal	2023-11-10	Monthly	22	6.88%	8.50
ZTR	Dividend King	2024-02-09	Monthly	37	8.35%	8.50
PCF	Dividend King	2023-12-18	Monthly	38	7.05%	8.50
PVL	Dividend King	2023-11-15	Monthly	14	9.37%	8.50
KIO	Dividend Royal	2023-12-14	Monthly	12	7.05%	8.50
NCV	Dividend Royal	2024-02-09	Monthly	22	7.68%	8.50
SBR	Dividend Royal	2023-11-14	Monthly	38	7.74%	8.50
SCM	Dividend King	2023-12-15	Monthly	13	7.08%	8.50
MTR	Dividend Diamond	2023-10-30	Monthly	39	10.10%	8.50

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.274	1.500	4.51	6.77	[0 - 0.5]
returnOnAssetsTTM	0.164	1.200	4.53	5.44	[0 - 0.3]
returnOnEquityTTM	0.488	1.500	5.68	8.53	[0.1 - 1]
payoutRatioTTM	0.295	-1.000	7.05	-7.05	[0 - 1]
currentRatioTTM	3.36	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	1.771	0.800	4.29	3.43	[0.8 - 2.5]
cashRatioTTM	1.080	1.500	5.11	7.66	[0.2 - 2]
debtRatioTTM	0.463	-1.500	2.28	-3.42	[0 - 0.6]
interestCoverageTTM	12.94	1.000	6.32	6.32	[3 - 30]
operatingCashFlowPerShareTTM	5.13	2.00	8.29	10.00	[0 - 30]
freeCashFlowPerShareTTM	3.53	2.00	8.23	10.00	[0 - 20]
debtEquityRatioTTM	1.324	-1.500	4.70	-7.06	[0 - 2.5]
grossProfitMarginTTM	0.696	1.000	1.735	1.735	[0.2 - 0.8]
operatingProfitMarginTTM	0.374	1.000	4.52	4.52	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.356	1.000	9.13	9.13	[0.2 - 2]
assetTurnoverTTM	0.598	0.800	9.35	7.48	[0.5 - 2]
Total Score				10.25

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	32.75	1.000	6.79	0	[1 - 100]
returnOnEquityTTM	0.488	2.50	7.23	8.53	[0.1 - 1.5]
freeCashFlowPerShareTTM	3.53	2.00	8.82	10.00	[0 - 30]
dividendYielPercentageTTM	0.965	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	5.13	2.00	8.29	10.00	[0 - 30]
payoutRatioTTM	0.295	1.500	7.05	-7.05	[0 - 1]
pegRatioTTM	0	1.500	-3.33	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.275	1.000	5.62	0	[0.1 - 0.5]
Total Score				5.74

Zoetis Inc

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms. It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides portable blood and urine analysis testing, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.